404 related articles for article (PubMed ID: 31729564)
1. The gut microbiome in tuberculosis susceptibility and treatment response: guilty or not guilty?
Eribo OA; du Plessis N; Ozturk M; Guler R; Walzl G; Chegou NN
Cell Mol Life Sci; 2020 Apr; 77(8):1497-1509. PubMed ID: 31729564
[TBL] [Abstract][Full Text] [Related]
2. Microbiome-immune interactions in tuberculosis.
Mori G; Morrison M; Blumenthal A
PLoS Pathog; 2021 Apr; 17(4):e1009377. PubMed ID: 33857251
[TBL] [Abstract][Full Text] [Related]
3. The host microbiome and impact of tuberculosis chemotherapy.
O'Toole RF; Gautam SS
Tuberculosis (Edinb); 2018 Dec; 113():26-29. PubMed ID: 30514510
[TBL] [Abstract][Full Text] [Related]
4. Gut Mycobiota Dysbiosis in Pulmonary Tuberculosis Patients Undergoing Anti-Tuberculosis Treatment.
Cao D; Liu W; Lyu N; Li B; Song W; Yang Y; Zhu J; Zhang Z; Zhu B
Microbiol Spectr; 2021 Dec; 9(3):e0061521. PubMed ID: 34908436
[TBL] [Abstract][Full Text] [Related]
5. Gut Microbiota Regulates Mincle Mediated Activation of Lung Dendritic Cells to Protect Against
Negi S; Pahari S; Bashir H; Agrewala JN
Front Immunol; 2019; 10():1142. PubMed ID: 31231363
[TBL] [Abstract][Full Text] [Related]
6. The Microbiome and Tuberculosis: Early Evidence for Cross Talk.
Namasivayam S; Sher A; Glickman MS; Wipperman MF
mBio; 2018 Sep; 9(5):. PubMed ID: 30228238
[TBL] [Abstract][Full Text] [Related]
7. The gut microbiota mediates protective immunity against tuberculosis
Yang F; Yang Y; Chen L; Zhang Z; Liu L; Zhang C; Mai Q; Chen Y; Chen Z; Lin T; Chen L; Guo H; Zhou L; Shen H; Chen X; Liu L; Zhang G; Liao H; Zeng L; Zeng G
Gut Microbes; 2022; 14(1):2029997. PubMed ID: 35343370
[TBL] [Abstract][Full Text] [Related]
8. The role of microbiota in respiratory health and diseases, particularly in tuberculosis.
Shah T; Shah Z; Baloch Z; Cui X
Biomed Pharmacother; 2021 Nov; 143():112108. PubMed ID: 34560539
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiome dysbiosis and correlation with blood biomarkers in active-tuberculosis in endemic setting.
Khaliq A; Ravindran R; Afzal S; Jena PK; Akhtar MW; Ambreen A; Wan YY; Malik KA; Irfan M; Khan IH
PLoS One; 2021; 16(1):e0245534. PubMed ID: 33481833
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota associated with pulmonary tuberculosis and dysbiosis caused by anti-tuberculosis drugs.
Hu Y; Yang Q; Liu B; Dong J; Sun L; Zhu Y; Su H; Yang J; Yang F; Chen X; Jin Q
J Infect; 2019 Apr; 78(4):317-322. PubMed ID: 30107196
[TBL] [Abstract][Full Text] [Related]
11. Intestinal microbiota disruption limits the isoniazid mediated clearance of Mycobacterium tuberculosis in mice.
Negi S; Pahari S; Bashir H; Agrewala JN
Eur J Immunol; 2020 Dec; 50(12):1976-1987. PubMed ID: 32673409
[TBL] [Abstract][Full Text] [Related]
12. The gut and lung microbiota in pulmonary tuberculosis: susceptibility, function, and new insights into treatment.
Zhuo Q; Zhang X; Zhang K; Chen C; Huang Z; Xu Y
Expert Rev Anti Infect Ther; 2023; 21(12):1355-1364. PubMed ID: 37970631
[TBL] [Abstract][Full Text] [Related]
13. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
[TBL] [Abstract][Full Text] [Related]
14. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
15. Correlation between Disease Severity and the Intestinal Microbiome in Mycobacterium tuberculosis-Infected Rhesus Macaques.
Namasivayam S; Kauffman KD; McCulloch JA; Yuan W; Thovarai V; Mittereder LR; Trinchieri G; Barber DL; Sher A
mBio; 2019 Jun; 10(3):. PubMed ID: 31164469
[TBL] [Abstract][Full Text] [Related]
16. Impact of tuberculosis disease on human gut microbiota: a systematic review.
Baral T; Kurian SJ; Thomas L; Udyavara Kudru C; Mukhopadhyay C; Saravu K; Manu MK; Singh J; Munisamy M; Kumar A; Khandelwal B; Rao M; Sekhar Miraj S
Expert Rev Anti Infect Ther; 2023 Feb; 21(2):175-188. PubMed ID: 36564016
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal profiling of gut microbiome among tuberculosis patients under anti-tuberculosis treatment in China: protocol of a prospective cohort study.
Shi W; Hu Y; Zheng X; Ning Z; Wu M; Xia F; Prast-Nielsen S; Hu YOO; Xu B
BMC Pulm Med; 2019 Nov; 19(1):211. PubMed ID: 31711450
[TBL] [Abstract][Full Text] [Related]
18. Antituberculosis Therapy and Gut Microbiota: Review of Potential Host Microbiota Directed-Therapies.
Diallo D; Somboro AM; Diabate S; Baya B; Kone A; Sarro YS; Kone B; Diarra B; Diallo S; Diakite M; Doumbia S; Toloba Y; Murphy RL; Maiga M
Front Cell Infect Microbiol; 2021; 11():673100. PubMed ID: 34950603
[TBL] [Abstract][Full Text] [Related]
19. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
Woodhouse CA; Patel VC; Singanayagam A; Shawcross DL
Aliment Pharmacol Ther; 2018 Jan; 47(2):192-202. PubMed ID: 29083037
[TBL] [Abstract][Full Text] [Related]
20. The Host Microbiota Contributes to Early Protection Against Lung Colonization by
Dumas A; Corral D; Colom A; Levillain F; Peixoto A; Hudrisier D; Poquet Y; Neyrolles O
Front Immunol; 2018; 9():2656. PubMed ID: 30487801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
